Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.39
Delayed Data
As of Apr 26
 -0.12 / -1.60%
Today’s Change
6.15
Today|||52-Week Range
11.34
-17.89%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Kidron Miriam
Chief Scientific Officer
Sale8/02/201789,636$8.50$761.9K-8.65%
Li Xiaopeng /oramed/
Director
Buy8/02/201789,636$8.50$761.9K-8.65%
Regals Capital Management Lp
Director
Buy8/17/2017112,613$3.77$424.6K-9.44%
Sank Leonard
Director
Buy8/15/201711,262$6.00$67.6K-7.62%
Regals Capital Management Lp
Director
Buy10/31/201716,892$3.77$63.7K-25.50%
Sank Leonard
Director
Buy10/23/20176,373$6.00$38.2K-30.28%
Sank Leonard
Director
Buy10/23/20175,631$6.00$33.8K-30.28%
Kidron Miriam
Chief Scientific Officer
Gift6/30/201775,000$0.00$0.00-4.89%